Astrazeneca PLC (AZN) News

Astrazeneca PLC (AZN): $56.60

0.15 (+0.27%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter AZN News Items

AZN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

AZN News Highlights

  • For AZN, its 30 day story count is now at 71.
  • Over the past 27 days, the trend for AZN's stories per day has been choppy and unclear. It has oscillated between 1 and 13.
  • III, LUNG and PFS are the most mentioned tickers in articles about AZN.

Latest AZN News From Around the Web

Below are the latest news stories about Astrazeneca Plc that investors may wish to consider to help them evaluate AZN as an investment opportunity.

How the AHEAD100 Initiative is working to prevent future pandemics

Dr. James Crowe, Vanderbilt Vaccine Center Director & Ahead100 Initiative Founder, joined Yahoo Finance Live to discuss the role of antibody research in preventing and preparing for future pandemics. 

Yahoo | September 13, 2021

Florida turns to Covid-detecting dogs amid surging cases 


Dr. Kenneth Furton, Provost, Executive Vice President and COO at Florida International University, joins Yahoo Finance to discuss Miami International Airport’s Covid-detecting dogs with 97.5% accuracy in detecting Covid-19.

Yahoo | September 13, 2021

NYC has a good plan so far for keeping kids safe as they return to the classroom: Doctor

Dr. Susannah Hills, Pediatric Airway Surgeon and Assistant Professor of ENT at Columbia University Medical Center, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.

Yahoo | September 13, 2021

Got $3,000? Keep It Safe With These 3 Healthcare Stocks

They offer products that their customers absolutely can't do without, and they also pay dividends.

Yahoo | September 13, 2021

3 No-Brainer Stocks to Invest $100 in Right Now

You don't need a giant pile of cash to generate a healthy return from this trio of growth, value, and income stocks.

Yahoo | September 13, 2021

Over 60s offered Pfizer in South Australia

South Australians aged over 60 will be able to line up for a Pfizer vaccination after the state announced they would not be limited to the AstraZeneca jab.

Perth Now | September 10, 2021

EMA warns of a new, serious side effect from the AstraZeneca Covid vaccination

The speed and success of the Covid vaccination campaign across the rich world has been breathtaking. Although ethical issues have been raised about the uneven distribution, falling death rates across developed countries shows scientific ingenuity as well as a strong public health policy. However, the effects of the vaccines must be monitored, even though getting [] EMA warns of a new, serious side effect from the AstraZeneca Covid vaccination

Newslanes | September 10, 2021

Widespread booster shots may not be needed for fully vaxxed

"Immunity," according to one of the leading scientists behind AstraZeneca''s COVID shot, "Is lasting well in the majority of people.

New York Daily News | September 10, 2021

COVID-19 vaccination campaign: 10,183 people immunised in last 24h

Romania''s National COVID-19 Vaccination Coordination Committee (CNCAV) has reported that in the last 24 hours, 10,183 doses of the Pfizer, Moderna, AstraZeneca and Johnson & Johnson COVID-19 vaccines were administered, 7,504 first doses and 2,679 second doses. Citete mai departe

Stiri pe surse | September 10, 2021

AstraZeneca hero criticises ''frustrating'' vaccine hesitancy after EU denounced Oxford jab

DAME SARAH GILBERT, the scientist whose tireless work led the development of the Oxford-AstraZeneca vaccine, is frustrated by people who continue to question the jab''s safety.

Daily Express | September 10, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7924 seconds.